在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

  Home>News Center>World
         
 

Potential HIV/AIDS vaccine gets more tests
(Agencies)
Updated: 2005-01-25 20:51

NEWARK, N.J. - A potential HIV/AIDS vaccine developed by Merck & Co. that uses synthetic genes to prepare cells to fight the deadly virus is moving into the second stage of testing.

An approved vaccine would be about a decade away if the trial and a third study are successful, said officials with the international coalition that is collaborating on the work.

"It is the most promising candidate that we've seen so far," said Sarah B. Alexander, associate director of the coalition, known as the HIV Vaccine Trials Network, or HVTN. She cautioned, however, "something better could come along tomorrow."

Volunteers began enrolling last month for the Phase II study, which will eventually give the potential vaccine's three doses to 1,500 people in North and South America, the Caribbean and Australia, the network and Whitehouse Station-based drug maker announced Monday.

The study is using male and female volunteers aged 18 to 45 of diverse racial groups who are at high risk for contracting HIV. Participants will receive counseling about how to reduce their risk of HIV infection, Alexander said.

About a dozen companies and organizations worldwide are attempting to develop an AIDS vaccine. Of the 10 associated with HVTN, the Merck candidate is the first to reach Phase II testing, Alexander said.

Of the two that reached Phase III, the final stage before certification is sought, one was deemed unsuccessful in 2000, and another, led by the U.S. Department of Defense, is enrolling volunteers, she said.

The Merck candidate — the MRKAd5 HIV-1 gag/pol/nef, or trivalent, vaccine — is designed to persuade the defenders of each cell, called "killer T cells," to attack HIV when the virus enters the cell. Other vaccines generate an antibody response.

The potential vaccine uses the virus of a common cold, modified so it cannot reproduce or cause people to catch a cold, to transport three synthetically produced HIV genes to the cells.

"We give the body enough of the virus so it can recognize it and create an immune response," but not enough to infect a person, Alexander said.

The Phase I study of the possible vaccine, involving about 1,000 people, "generated strong and durable cellular immune responses against HIV," Merck spokeswoman Janet Skidmore said.

Seattle-based HVTN is funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, an agency of the US Department of Health and Human Services, and comprises more than 25 research institutions worldwide.

Merck shares fell 51 cents, or 1.7 percent, to close at $29.85 in Monday trading on the New York Stock Exchange. The stock, which has fallen sharply since Merck withdrew its Vioxx drug from the market amid safety concerns, has traded in a 52-week range of $25.60 to $49.33.



 
  Today's Top News     Top World News
 

China's GDP grows 9.5% in 2004, higher than forecasts

 

   
 

Revision of law to upgrade mine safety

 

   
 

FM says released men to fly back soon

 

   
 

Myanmar nabs drug lord, sends him back

 

   
 

China seeks to curb corruption in big SOEs

 

   
 

Bank officials flee after US$120m go missing

 

   
  Potential HIV/AIDS vaccine gets more tests
   
  Stampede at Hindu procession kills 150
   
  11 policemen killed in Baghdad clashes
   
  UN: World needs the will to stop genocide
   
  Iraq forces arrest top al-Qaida lieutenant
   
  Torture still routine in Iraqi jails: report
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Related Stories  
   
Shanxi to test blood sellers for HIV
   
Checking mother-to-child HIV transmission
   
India to step up AIDS fight, launch media campaign
   
Boosting rights of HIV victims
   
Thai-Chinese anti-HIV drug 89% effective
   
HIV pregnant women to be treated free
   
HIV infection rates unchanged in US
  News Talk  
  Are the Republicans exploiting the memory of 9/11?  
Advertisement
         
主站蜘蛛池模板: 五月天激情视频 | 天天躁日日躁狠狠躁 | 欧美日韩性 | 五月婷婷在线视频 | 国产精品xxx | 午夜天堂在线 | 久久综合久色欧美综合狠狠 | 日韩精品二区 | 免费看黄色aaaaaa 片 | 涩五月婷婷 | 日韩免费高清视频 | 懂色av一区二区三区 | 夜夜骑夜夜操 | 日本在线观看网站 | 日本熟妇毛耸耸xxxxxx | 日韩视频在线观看免费 | 午夜你懂的 | 亚洲蜜桃av | 久久久不卡 | 日本不卡视频在线观看 | 日韩三级在线播放 | 免费看a| 九九视频在线免费观看 | www.国产视频 | 天天躁日日躁bbbbb | 日韩精品观看 | 91精品国产成人www | 视频一区二区在线播放 | 成人一级黄色片 | 国产精品一区二区三区四区五区 | 精品久久久久久久久久久久 | 久久久精品在线观看 | 久色91| 91精品国产色综合久久不卡98 | 国产黄色免费 | 亚洲免费在线观看 | 男女av在线| 99在线精品视频 | 国产精品成人免费精品自在线观看 | 天堂中文在线资 | 免费在线观看毛片 |